Cardiac MRI
7
1
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Non-invasive Prediction of EArly Cardiac rEjection
Feasibility, Safety and Diagnostic Input of Interventional Cardiac MRI on a Series of 35 Patients With an Indication of Right Cardiac Catheterization.
Validation of Thermometric Cardiac Imaging by MRI
Screening, Characterization, and Longitudinal Follow-up of Patients With Cardiac Amyloidosis
Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)
Dobutamine vs Adenosine CMR Study
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients